Published in Obesity and Diabetes Week, July 5th, 2004
"Because exenatide has multiple underlying antidiabetes actions - as well as the ability to promote weight loss, which is often important for people with type 2 diabetes - it holds the potential to be a pivotally important drug in diabetes care," said Ralph DeFronzo, MD, professor of medicine and chief of the diabetes division, University of Texas Health Science Center, San Antonio,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.